Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Ceftazidime (2gm) + Avibactam (0.5gm) Injection
Dosage Form : Injection
Packaging Type : Vial
Packaging : 2.5gm
Price : ₹1/-
Dimezeft 2.5 Injection contains a potent combination of Ceftazidime (2gm) and Avibactam (0.5gm). Ceftazidime is a third-generation cephalosporin antibiotic with broad-spectrum activity against many Gram-negative and some Gram-positive bacteria. Avibactam is a non-beta-lactam beta-lactamase inhibitor that protects Ceftazidime from degradation by certain resistant bacteria, thereby significantly enhancing its effectiveness.
This combination is especially effective against multi-drug resistant (MDR) infections, including those caused by extended-spectrum beta-lactamase (ESBL) and carbapenem-resistant strains.
It helps in the treatment of complicated intra-abdominal infections, complicated urinary tract infections (including pyelonephritis), hospital-acquired pneumonia (including ventilator-associated pneumonia), and other life-threatening drug-resistant bacterial infections.
Common side effects may include nausea, vomiting, diarrhea, constipation, headache, and pain at the injection site. Rare but serious effects may include allergic reactions, changes in liver or kidney function, or Clostridium difficile-associated diarrhea.
Indicated for the treatment of serious and drug-resistant bacterial infections, especially in hospital settings. Effective in treating infections of the lungs, abdomen, urinary tract, and bloodstream caused by resistant organisms.
This injection is intended for use only under strict medical supervision, typically in a hospital. Inform your doctor of any known allergies, especially to cephalosporins or penicillins. Dosage adjustments may be needed in patients with renal impairment. Always complete the full course of therapy.
Store below 25°C in a dry place. Protect from direct light. Once reconstituted, use immediately or as per healthcare provider instructions. Keep out of reach of children.
Composition : Ceftazidime (1gm)
Composition : Ceftazidime (250mg)
Composition : Ceftazidime (250mg) + Sulbactam (125mg)
Composition : Ceftazidime (1000mg) + Tazobactum (125mg)
Composition : Ceftazidime (1000mg) + Sulbactam (500mg)
Composition : Levofloxacin 500mg Infusion
Composition : Linezolid Intravenous Infusion I.P. 2mg Infusion
Composition : Moxifloxacin IP 400 mg + Mannitol IP 5.0% w/v Infusuion
Composition : Azithromycin (500mg) Injection
Composition : Biapenem (300mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation